Related Experiment Video
Updated: Aug 24, 2025
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
17.9K
Highly Efficient Real-Time TRPV1 Screening Methodology for Effective Drug Candidates
Seong Gi Lim1, Sung Eun Seo1,2, Seongjae Jo1
1Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
ACS Omega
|October 24, 2022
Summary
Researchers developed a novel graphene field-effect transistor biosensor for rapidly screening potential TRPV1-targeting drugs. This innovation accelerates the discovery of new pain and cancer treatments by identifying effective vanilloid compounds efficiently.
Area of Science:
- Biotechnology and Biosensor Development
- Pharmacology and Drug Discovery
- Materials Science
Background:
- Transient receptor potential vanilloid 1 (TRPV1) agonists are crucial for developing treatments for chronic pain and cancer.
- Current drug candidate selection for synthetic vanilloids is a slow, multi-step process, necessitating faster screening methods.
- Capsaicin, a known TRPV1 agonist, has side effects that limit its therapeutic use, driving the search for alternatives.
Purpose of the Study:
- To introduce a novel field-effect transistor (FET) biosensor for rapid and efficient screening of vanilloid compounds targeting TRPV1.
- To facilitate the discovery of new TRPV1-targeting medications with potentially fewer side effects than capsaicin.
- To establish a high-throughput screening platform for drug development.
Main Methods:
- Fabrication of a graphene field-effect transistor (gFET) biosensor utilizing human TRPV1 receptor protein as the bioprobe.
- Characterization of the fabricated gFET using Scanning Electron Microscopy (SEM), Raman spectroscopy, and Fourier-Transform Infrared (FT-IR) spectroscopy.
- Computational simulations using AutoDock Vina/PyMOL to assess the binding affinity of capsaicin, olvanil, and arvanil to TRPV1.
Main Results:
- Successful fabrication of the gFET biosensor with integrated human TRPV1 receptor protein was confirmed through material analysis.
- Binding interactions between vanilloid ligands (capsaicin, olvanil, arvanil) and the TRPV1 receptor were successfully detected by the biosensor.
- Experimental results from the biosensor platform showed strong correlation with in-silico binding affinity simulations.
Conclusions:
- The developed graphene FET biosensor provides a fast and facile platform for screening lead vanilloid compounds for TRPV1-targeting drug development.
- This approach significantly accelerates the identification of potential therapeutic agents for chronic pain and cancer.
- The study demonstrates the potential of FET-based biosensors in pharmaceutical research for efficient drug discovery.
Related Concept Videos
01:26Drug Discovery: Overview
8.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.3K
01:18Patch Clamp
5.6K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.6K